Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
82,244 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Sep 30, 2026 | AmeriHealth | Pharmacogenetics and Metabolite Monitoring for Using Azathioprine (AZA)/6-Mercaptopurine (6-MP) Therapy (AmeriHealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-18M-95E9099841 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Peroral Endoscopic Myotomy (POEM) ProceduresPayerPolicy · AMERIHEALTH-COMMERCIAL-11-03-17A-0159C879F2 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound (AmeriHealth)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-02-27N-070881C753 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Pembrolizumab and berahyaluronidase alfa-pmph (Keytruda QLEX)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-49A-C036BD2970 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Pembrolizumab (Keytruda)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-63F-844085C16F | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Pediatric Intensive Day Feeding ProgramPayerPolicy · AMERIHEALTH-COMMERCIAL-10-00-03-F8C03C643A | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Outpatient Physical Medicine, Rehabilitation, and Habilitation ServicesPayerPolicy · AMERIHEALTH-COMMERCIAL-10-03-01O-B10431066B | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Otoplasty or Non-Surgical External Ear MoldingPayerPolicy · AMERIHEALTH-COMMERCIAL-11-01-01J-9B3CF20F50 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Osteogenic Stimulators (non-invasive, invasive/semi-invasive, electrical and ultrasound)PayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-81A-C3C487AD75 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Orthognathic SurgeryPayerPolicy · AMERIHEALTH-COMMERCIAL-11-14-08D-DD32341884 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Ocrelizumab (Ocrevus) and Ocrelizumab and Hyaluronidase-ocsq (Ocrevus Zunovo)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-38E-3F9E746FE3 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Nivolumab (Opdivo), Nivolumab and Hyaluronidase-nvhy (Opdivo Qvantig)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-62G-624EC04030 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | New Jersey Health Maintenance Organization (HMO) and Health Maintenance Organization Point-of-Service (HMO-POS) Radiology Network Rules and Limited CircumstancesPayerPolicy · AMERIHEALTH-COMMERCIAL-00-01-55AB-15D75D155B | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Neuropsychological Testing for Neurologically Based ConditionsPayerPolicy · AMERIHEALTH-COMMERCIAL-07-03-08O-F7BB2AF416 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Musculoskeletal Services (AmeriHealth)PayerPolicy · AMERIHEALTH-COMMERCIAL-00-01-66T-E2FDD96D23 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Multiple Surgery Payment ReductionPayerPolicy · AMERIHEALTH-COMMERCIAL-11-00-10Y-4F1B595D75 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Mogamulizumab-kpkc (Poteligeo)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-52G-E365CF8CF8 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Modifiers 26 (Professional Component) and TC (Technical Component)PayerPolicy · AMERIHEALTH-COMMERCIAL-03-00-20T-8D6A373E86 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Medical NecessityPayerPolicy · AMERIHEALTH-COMMERCIAL-12-01-02C-A284BDF2EF | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Measurement of Serum Antibodies to and Measurement of Serum Levels of BiologicsPayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-39D-8DCA1345D5 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Lumasiran (Oxlumo)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-74C-EF498BF9C7 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Laser Interstitial Thermal Therapy (LITT)PayerPolicy · AMERIHEALTH-COMMERCIAL-07-03-28-674AC5CA7B | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Lanreotide (Somatuline Depot)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-40H-490B362EE8 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Laboratory Services for Members Enrolled in Health Maintenance Organization (HMO) or Health Maintenance Organization Point-of-Service (HMO-POS) ProductsPayerPolicy · AMERIHEALTH-COMMERCIAL-00-03-07AS-F8608F623E | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists, VEGF Biosimilars, and Combination VEGF/Angiopoietin-2 (Ang-2) InhibitorsPayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-74AC-7261815FF3 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Insulin Pumps and Long-Term Interstitial Continuous Glucose Monitoring SystemsPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-79L-00EBABFCE8 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | High-Technology Radiology ServicesPayerPolicy · AMERIHEALTH-COMMERCIAL-09-00-46AW-B0FBC1709B | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Hair Transplants and Cranial Prostheses (Wigs)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-08-01H-81CDB23DF1 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Genetic Testing for Inherited Susceptibility to Colon Cancer and Microsatellite Instability Testing (Familial Adenomatous Polyposis and Lynch Syndrome) (AmeriHealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-10R-3E52DD5084 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Genetic Testing for Inherited Breast Cancer 1 (BRCA1) and Breast Cancer 2 (BRCA2) Mutations (AmeriHealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-06S-6F6995B0D0 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Fertility Preservation (AmeriHealth New Jersey)PayerPolicy · AMERIHEALTH-COMMERCIAL-07-10-08H-2FCED0E8A4 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Facility Reporting of Observation ServicesPayerPolicy · AMERIHEALTH-COMMERCIAL-00-01-19E-3465CEBFD8 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | eviCore Lab Management (AmeriHealth)PayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-52AN-47EA88A077 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Endoscopic Submucosal Dissection (ESD)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-03-18-E99D06A337 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Durvalumab (Imfinzi) and Tremelimumab-actl (Imjudo)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-65E-6A5FDE04D4 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Drugs, Biologics, or Gene Therapies with an Accelerated ApprovalPayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-35-1A30833231 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Day RehabilitationPayerPolicy · AMERIHEALTH-COMMERCIAL-10-00-02C-CDB31CE0FB | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Daratumumab (Darzalex), Daratumumab and Hyaluronidase-fihj (Darzalex Faspro)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-29M-78930CC7CD | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Corneal Pachymetry Using UltrasoundPayerPolicy · AMERIHEALTH-COMMERCIAL-07-13-07M-ECECEF453C | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Care Management and Care Planning ServicesPayerPolicy · AMERIHEALTH-COMMERCIAL-00-01-59P-FBAA46734E | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Bioimpedance for the Detection of LymphedemaPayerPolicy · AMERIHEALTH-COMMERCIAL-07-06-03C-A2B9386AE5 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Atezolizumab (Tecentriq) and Atezolizumab with Hyaluronidase-tqjs (Tecentriq Hybreza)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-69F-3EEA363016 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Assays of Genetic Expression in Tumor Tissue for Breast Cancer Prognosis (AmeriHealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-27P-777A0F2EB0 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Aqueous Shunts, Microstents, Viscocanalostomy, and Canaloplasty for the Treatment of GlaucomaPayerPolicy · AMERIHEALTH-COMMERCIAL-11-05-16M-32EB2A875D | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Acute Care Facility Inpatient TransfersPayerPolicy · AMERIHEALTH-COMMERCIAL-12-04-04B-5E4D960B3B | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Alemtuzumab (Lemtrada)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-22E-7353D6B467 | Retired |
|---|
| Sep 30, 2026 | AmeriHealth | Ustekinumab for Intravenous InfusionPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-042 | New policy |
|---|
| Sep 30, 2026 | AmeriHealth | Treatments for Complex Regional Pain Syndrome (CRPS)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-026 | New policy |
|---|
| Sep 30, 2026 | AmeriHealth | Tocilizumab and Related Biosimilars for Intravenous Infusion and Subcutaneous InjectionPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-045 | New policy |
|---|
| Sep 30, 2026 | AmeriHealth | Tildrakizumab-asmn (Ilumya)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-098 | New policy |
|---|